- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04217863
To Observe the Psychophysiological Alterations in Traumatic Stress Subjects
Effects of the Guided Disclosure Protocol on Post-Traumatic Growth: A Randomized Control Trial Designed to Observe Psychophysiological Alterations in Traumatic Stress Subjects
연구 개요
상세 설명
Study design:
The study will be conducted as multicenter randomized controlled trial. On the basis of eligibility criteria subjects providing consent to participate in the study will be randomized into two groups, experimental group including those who receive the intervention and a control group receiving control intervention. The study outcomes will be monitored in subjects of both groups at different intervals i.e. at baseline and at 3-month follow-up (post-interventional).
Participants Subjects for the present study will be recruited from 5 centers (based in Karachi, Pakistan). The targeted population includes subjects from diverse ethnicity and considered eligible for participation in the study if they indicated in a pre-screening form that they had experienced traumatic event. These subjects will be invited to participate in the study through advertisement on notice board of each center. A written informed consent will be obtained from each study subject after providing detailed information regarding objectives of the study and its duration.
Interventions
The experimental intervention (GDP):
It includes three writing sessions of 20 minutes where the participants will be made to recall the facts regarding the traumatic event first and then the emotions triggered related to the revealed facts will be channelized. The information related to the immediate priority changes due to the revival of the traumatic history and its reflection on current feelings will be collected. Moreover, the learned coping mechanisms will also be inquired and how the traumatic event altered their vision and their personalities and how it helps in coping with future difficulties.
The original instructions will be translated into local language and altered according to the specific traumatic experience.
In the following, a fusion of the tasks concerning each of the three writing sessions is shown.
- Participants will be required to describe memories associated with traumatic event in a sequential order, with an objective and detached attitude
They will be asked to describe
- Their opinion regarding the traumatic event and emotions perceived during the experience
- Its impact on their daily lives, and how it has altered their attitudes toward life.
The actual situation will be focused, while reviving the whole traumatic event experience which aids in exploring the following aspects:
- Present thoughts and feelings regarding the traumatic experience, and also clarify the differences between the ones felt at the time of traumatic event in comparison to the current feelings.
- How much they understand and appreciate themselves for successfully dealing with the traumatic event
- To what extent the traumatic event has modified their vision, attitude, knowledge, and skills, and how it can help in their future;
- What will be their future reactions to other similar events. For the writing session it is mandatory to maintain standard experimental environment with maximum silence so that the subject can write peacefully without getting disturbed. Two weeks after the initial assessment, the first writing session will be performed followed by two sessions once every 2 weeks.
The control intervention:
In control intervention the subjects will be required to take three 20-minute writing sessions, in which they will be asked to write about their daily events of the past week, the writing must focus on the facts and highlight an objective and detached attitude. It has shown potential improvements after the guided disclosure protocol (GDP). Works through the placebo effect. Same protocol will be followed for these subjects as the one used for GDP.
A day prior to each writing session, in both conditions either experimental or control the researcher will communicate with each study subject via telephone in order to give them a reminder to perform the writing task and to check their understanding regarding the instructions given in the booklet. Details regarding the inability to contact the subject will also be recorded in the patient form.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Sindh
-
Karachi, Sindh, 파키스탄, 78500
- Shamoon Noushad
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Must be disease free, there must be no evidence of any metastatic disease
- Property of written and spoken the English language.
- Experienced any traumatic event in the last 12 Months
Exclusion Criteria:
- Subjects who received a structured psychological intervention for at least 6 months during the last 3 years performed by a psychologist or psychiatrist will be excluded.
- Those with a codified psychiatric disorder (according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) who received Psychopharmacological treatment during the last 3 years will also be excluded from the study sample.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: The experimental intervention (GDP): It includes three writing
|
Guided Disclosure Protocol
|
간섭 없음: The control intervention:
A day prior to each writing session, the researcher will communicate with each study subject via telephone in order to give them a reminder to perform the writing task and to check their understanding regarding the instructions given in the booklet.
Details regarding the inability to contact the subject will also be recorded in the patient form.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Post-Traumatic Growth (PTG)
기간: 3 Months
|
Change in the Post-traumatic Growth Inventory (PTGI) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
C- Reactive Protein (CRP)
기간: 3 Months
|
Change in the CRP level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Brain-derived neurotrophic factor (BDNF)
기간: 3 Months
|
Change in the BDNF level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Interleukin-6 (IL-6)
기간: 3 Months
|
Change in the IL-6 level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Glutamate
기간: 3 Months
|
Change in the Glutamate level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Cortisol
기간: 3 Months
|
Change in the Cortisol level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Alpha waves
기간: 3 Months
|
Change in the Brain waves (Alpha waves) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Heart Rate Variability
기간: 3 Months
|
Change in the Heart Rate Variability will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Beta waves
기간: 3 Months
|
Change in the Brain waves (Beta waves) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Trauma Symptom Checklist 40 (TSC-40)
기간: 3 Months
|
Change in the Trauma Symptom Checklist 40 (TSC-40) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Traumatic Stress Scale (Sadaf Stress Scale)
기간: 3 Months
|
Change in the Traumatic Stress Scale will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Gandubert C, Scali J, Ancelin ML, Carriere I, Dupuy AM, Bagnolini G, Ritchie K, Sebanne M, Martrille L, Baccino E, Hermes A, Attal J, Chaudieu I. Biological and psychological predictors of posttraumatic stress disorder onset and chronicity. A one-year prospective study. Neurobiol Stress. 2016 Feb 4;3:61-67. doi: 10.1016/j.ynstr.2016.02.002. eCollection 2016 Jun.
- Kalisch R, Muller MB, Tuscher O. A conceptual framework for the neurobiological study of resilience. Behav Brain Sci. 2015;38:e92. doi: 10.1017/S0140525X1400082X. Epub 2014 Aug 27.
- Cai WP, Pan Y, Zhang SM, Wei C, Dong W, Deng GH. Relationship between cognitive emotion regulation, social support, resilience and acute stress responses in Chinese soldiers: Exploring multiple mediation model. Psychiatry Res. 2017 Oct;256:71-78. doi: 10.1016/j.psychres.2017.06.018. Epub 2017 Jun 8.
- Liu AN, Wang LL, Li HP, Gong J, Liu XH. Correlation Between Posttraumatic Growth and Posttraumatic Stress Disorder Symptoms Based on Pearson Correlation Coefficient: A Meta-Analysis. J Nerv Ment Dis. 2017 May;205(5):380-389. doi: 10.1097/NMD.0000000000000605.
- Linz R, Puhlmann LMC, Apostolakou F, Mantzou E, Papassotiriou I, Chrousos GP, Engert V, Singer T. Acute psychosocial stress increases serum BDNF levels: an antagonistic relation to cortisol but no group differences after mental training. Neuropsychopharmacology. 2019 Sep;44(10):1797-1804. doi: 10.1038/s41386-019-0391-y. Epub 2019 Apr 16.
- Alper B, Erdogan B, Erdogan MO, Bozan K, Can M. Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers (IL1beta, IL6, TNFalpha, and CRP). Mediators Inflamm. 2016;2016:9894716. doi: 10.1155/2016/9894716. Epub 2016 Apr 5.
- Smith HE, Jones CJ, Hankins M, Field A, Theadom A, Bowskill R, Horne R, Frew AJ. The effects of expressive writing on lung function, quality of life, medication use, and symptoms in adults with asthma: a randomized controlled trial. Psychosom Med. 2015 May;77(4):429-37. doi: 10.1097/PSY.0000000000000166.
- Gidron Y, Duncan E, Lazar A, Biderman A, Tandeter H, Shvartzman P. Effects of guided written disclosure of stressful experiences on clinic visits and symptoms in frequent clinic attenders. Fam Pract. 2002 Apr;19(2):161-6. doi: 10.1093/fampra/19.2.161.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
기타 연구 ID 번호
- KU-Psychophysiology-5
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
GDP에 대한 임상 시험
-
Cancer Institute and Hospital, Chinese Academy...알려지지 않은
-
Cancer Institute and Hospital, Chinese Academy...완전한
-
Shandong Provincial Hospital알려지지 않은간비장 T 세포 림프종 | 달리 명시되지 않은 말초 T 세포 림프종 | ALK 음성 역형성 대세포 림프종 | 혈관면역모세포성 T 세포 림프종 | 장병증 관련 T 세포 림프종 | T 세포 림프종과 같은 피하 지방층염중국
-
Seoul National University Hospital아직 모집하지 않음미만성 대형 B 세포 림프종 | 난치성 비호지킨 림프종 | 재발성 비호지킨 림프종대한민국
-
Nanjing NingQi Medicine Science and Technology...Jiangsu Cancer Institute & Hospital알려지지 않은
-
Dipenkumar ModiGenmab모병재발된 암 | 난치성 암 | 미만성 대세포 림프종미국